Literature DB >> 12727154

Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function.

Finn Gustafsson1, Christian Torp-Pedersen, Bente Brendorp, Marie Seibaek, Hans Burchardt, Lars Køber.   

Abstract

AIMS: The purpose of this study was to evaluate the influence of left ventricular systolic function on the survival in a large consecutive cohort of patients hospitalized with congestive heart failure and to determine how left ventricular systolic function interacts with co-morbid conditions in terms of prognosis. METHODS AND
RESULTS: Analysis of survival data from 5491 patients admitted for new or worsening heart failure to 34 departments of cardiology or internal medicine in Denmark from 1993-1996 was carried out. A standardized echocardiogram was available for 95% of the patients, and left ventricular systolic function was estimated using wall motion index score. Follow-up time was 5-8 years. Patients with preserved systolic function were older, more frequently female, and had less evidence of ischemia than patients with systolic dysfunction. After 1 year, 24% of the patients had died. Low wall motion index was a potent independent predictor of death (risk ratio for one unit increase, 0.60 (0.56-0.64)), and was of greater prognostic significance in younger patients and patients with a history of myocardial ischemia. However, even in patients with preserved systolic function, mortality was high (1 year mortality, 19%).
CONCLUSION: In hospitalized heart failure patients, particularly in younger patients with ischemic heart disease, mortality risk is inversely related to left ventricular systolic function.

Entities:  

Mesh:

Year:  2003        PMID: 12727154     DOI: 10.1016/s0195-668x(02)00845-x

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  32 in total

1.  [Guidelines for therapy of chronic heart failure].

Authors:  U C Hoppe; M Böhm; R Dietz; P Hanrath; H K Kroemer; A Osterspey; A A Schmaltz; E Erdmann
Journal:  Z Kardiol       Date:  2005-08

2.  Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry.

Authors:  Ryenn West; Li Liang; Gregg C Fonarow; Robb Kociol; Roger M Mills; Christopher M O'Connor; Adrian F Hernandez
Journal:  Eur J Heart Fail       Date:  2011-06-28       Impact factor: 15.534

3.  Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction.

Authors:  N P Nikitin; P H Loh; R de Silva; J Ghosh; O Y Khaleva; K Goode; A S Rigby; F Alamgir; A L Clark; J G F Cleland
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

Review 4.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 5.  Epidemiology and clinical course of heart failure with preserved ejection fraction.

Authors:  Carolyn S P Lam; Erwan Donal; Elisabeth Kraigher-Krainer; Ramachandran S Vasan
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

6.  Heart failure in patients with preserved and deteriorated left ventricular ejection fraction.

Authors:  A Varela-Roman; L Grigorian; E Barge; P Bassante; M G de la Peña; J R Gonzalez-Juanatey
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

7.  Heart failure with preserved left ventricular systolic function: a hospital cohort study.

Authors:  C Berry; K Hogg; J Norrie; K Stevenson; M Brett; J McMurray
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

Review 8.  Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.

Authors:  Annamaria Iorio; Andrea Pozzi; Michele Senni
Journal:  Curr Heart Fail Rep       Date:  2017-06

9.  Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure.

Authors:  Oleg Gorelik; Dorit Almoznino-Sarafian; Miriam Shteinshnaider; Irena Alon; Irma Tzur; Ilya Sokolsky; Shai Efrati; Zoanna Babakin; David Modai; Natan Cohen
Journal:  Clin Res Cardiol       Date:  2009-02-13       Impact factor: 5.460

10.  The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.

Authors:  Van Kimmenade
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.